Amyris to Participate in Panel Discussion at Cowen and Company 43rd Annual Technology, Media & Telecom Conference on May 28, ...
May 22 2015 - 7:30AM
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company,
today announced that it plans to participate in a panel discussion
entitled, "Closer Examination of Next-Generation Bioproduct
Technologies," at Cowen and Company's 43rd Annual Technology, Media
& Telecom Conference. The conference will be held May 27-28,
2015, at The New York Palace Hotel in New York City.
John Melo, President & CEO of Amyris, is scheduled to
participate on the panel on Thursday, May 28, 2015 at 2:45 p.m.
Eastern Time with one-on-one meetings with investors to be held in
conjunction with the conference. Due to the format, the panel
presentation is not being webcast.
About Amyris
Amyris is the integrated renewable products company that's
enabling the world's leading brands to achieve sustainable growth.
Amyris applies its innovative bioscience solutions to convert plant
sugars into hydrocarbon molecules, specialty ingredients and
consumer products. The company is delivering its No Compromise®
products in focused markets, including specialty and performance
chemicals, fragrance ingredients, and cosmetic emollients. More
information about the company is available at www.amyris.com.
Amyris is a registered trademark of Amyris, Inc.
CONTACT: Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@amyris.com
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Apr 2024 to May 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From May 2023 to May 2024